NCT00418366View on ClinicalTrials.gov

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Renal InsufficiencyHemodialysis
Interventions
DRUG

MK0431, sitagliptin phosphate / Duration of Treatment : 1 Days

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00418366 - A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008) | Biotech Hunter | Biotech Hunter